IDEXX Laboratories Inc
Veridion Score
Composite trend over time
Why is IDXX moving today?
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Real vendor fields plus Veridion-computed history. Missing fields stay blank.
Warehouse intelligence for IDXX.
IDXX insider activity
IDEXX Laboratories Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$20.7M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-02 | 2026-06-01 | FENNELL GEORGE | Insider | sell | $566.79 | 284 | 10,433 | $161K | SEC Form 4 |
| 2026-05-04 | 2026-04-30 | HOOLEY JOSEPH L | Insider | buy | $560.80 | 43 | 118 | $24K | SEC Form 4 |
| 2026-03-05 | 2026-03-03 | Hunt Nimrata | Insider | sell | $634.57 | 1,758 | 18,141 | $1.1M | SEC Form 4 |
| 2026-03-05 | 2026-03-03 | Underberg Sharon E. | Insider | buy | $505.53 | 197 | 7,138 | $100K | SEC Form 4 |
| 2026-03-02 | 2026-02-27 | MAZELSKY JONATHAN JAY | Insider | buy | $505.53 | 197 | 83,803 | $100K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 41 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moIDXX contract awards, year to date.
Public federal awards linked to this ticker.
IDXX lobbying filings, year to date.
Registered lobbying filings matched to IDEXX Laboratories Inc.